Piramal Pharma Limited (PPL) declared on Tuesday that it signed a Master Services Agreement (MSA) to perform services related to the development, manufacture and supply of RNL-Liposome Intermediate Drug Product.
The MSA was reportedly signed between Piramal Pharma Limited's (PPL) Contract Development and Manufacturing Organization (CDMO), Piramal Pharma Solutions (PPS) and Plus Therapeutics Inc, a clinical-stage pharmaceutical company.
This MSA includes transfer of analytical methods, development of microbiological methods, process transfer and optimization, intermediate drug product manufacturing as well as stability studies. The transfer will be performed at the PPS drug product facility located in Lexington, Kentucky. MSA will lead to clinical and commercial supply agreements for the drug product at the appropriate stage of development.
In addition, PPS' Lexington site has the capability to support drug development for New Chemical Entities (NCEs), generics and molecules that might be following the 505(b)(2) regulatory pathway.
Apotex launches Teriparatide Injection in US
Teva Pharmaceuticals secures FDA approval for generic Forteo (teriparatide injection)
Upsher-Smith Laboratories introduces Pitavastatin Tablets
Par Pharmaceutical starts shipping colchicine 0.6mg capsules
Padagis launces Brinzolamide Ophthalmic Suspension with CGT exclusivity
Novartis completes Sandoz Spin-off
Novartis completes Sandoz spin-off, focusing on innovative medicines
Sanofi and Teva collaborate on innovative IBD treatment
Hikma marks KLOXXADO two-year anniversary by surpassing 375,000 doses donated in the US
STADA seeks full approval for Kinpeygo in IgA nephropathy from UK MHRA
Azurity Pharmaceuticals completes Slayback Pharma acquisition
Sandoz secures European approval for Tyruko biosimilar in MS treatment
Senores Pharmaceuticals introduces Nicardipine Hydrochloride Capsules USP, 20mg and 30mg in US
Lupin collaborates with Mark Cuban Cost Plus Drug Company and COPD foundation
Certara Simcyp receives FDA grants for advanced pharmacokinetic modelling